Post-market drug safety evidence sources: an analysis of FDA drug safety communications

被引：27

作者：

Ishiguro, Chieko ^{[1
]}

Hall, Marni ^{[2
]}

Neyarapally, George A. ^{[2
]}

Dal Pan, Gerald ^{[2
]}

机构：

[1] Pharmaceut & Med Devices Agcy, Off Safety 1, Div Surveillance & Anal, Tokyo, Japan

[2] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷 / 10期

关键词：

APROTININ; RISK; ROSIGLITAZONE; DEATH;

D O I：

10.1002/pds.3317

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1134 / 1136

页数：3

共 17 条

[11] Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study [J].

Leyland-Jones, B ;

Semiglazov, V ;

Pawlicki, M ;

Pienkowski, T ;

Tjulandin, S ;

Manikhas, G ;

Makhson, A ;

Roth, A ;

Dodwell, D ;

Baselga, J ;

Biakhov, M ;

Valuckas, K ;

Voznyi, E ;

Liu, XY ;

Vercammen, E .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5960-5972

[12] The risk associated with aprotinin in cardiac surgery [J].

Mangano, DT ;

Tudor, IC ;

Dietzel, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :353-365

[13] Potential Safety Signals and Their Significance [J].

Powers, Abbey ;

Cook, G. Elliott .

ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (01) :72-73

[14] Aprotinin during coronary-artery bypass grafting and risk of death [J].

Schneeweiss, Sebastian ;

Seeger, John D. ;

Landon, Joan ;

Walker, Alexander M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (08) :771-783

[15] The effect of aprotinin on outcome after coronary-artery bypass grafting. [J].

Shaw, Andrew D. ;

Stafford-Smith, Mark ;

White, William D. ;

Phillips-Bute, Barbara ;

Swaminathan, Madhav ;

Milano, Carmelo ;

Welsby, Ian J. ;

Aronson, Solomon ;

Mathew, Joseph P. ;

Peterson, Eric D. ;

Newman, Mark F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (08) :784-793

[16] Role of Postmarketing Surveillance in Contemporary Medicine [J].

Woodcock, Janet ;

Behrman, Rachel E. ;

Dal Pan, Gerald J. .

ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 :1-10

[17] Regulatory Action on Rosiglitazone by the US Food and Drug Administration [J].

Woodcock, Janet ;

Sharfstein, Joshua M. ;

Hamburg, Margaret .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (16) :1489-1491

← 1 2 →